BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16534812)

  • 21. Crystal structure of human SH3BGRL protein: the first structure of the human SH3BGR family representing a novel class of thioredoxin fold proteins.
    Yin L; Xiang Y; Zhu DY; Yan N; Huang RH; Zhang Y; Wang DC
    Proteins; 2005 Oct; 61(1):213-6. PubMed ID: 16080146
    [No Abstract]   [Full Text] [Related]  

  • 22. HD-PTP: A novel protein tyrosine phosphatase gene on human chromosome 3p21.3.
    Toyooka S; Ouchida M; Jitsumori Y; Tsukuda K; Sakai A; Nakamura A; Shimizu N; Shimizu K
    Biochem Biophys Res Commun; 2000 Nov; 278(3):671-8. PubMed ID: 11095967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of a putative NADPH-dependent oxidoreductase (GI: 18204011) from mouse at 2.10 A resolution.
    Levin I; Schwarzenbacher R; McMullan D; Abdubek P; Ambing E; Biorac T; Cambell J; Canaves JM; Chiu HJ; Dai X; Deacon AM; DiDonato M; Elsliger MA; Godzik A; Grittini C; Grzechnik SK; Hampton E; Jaroszewski L; Karlak C; Klock HE; Koesema E; Kreusch A; Kuhn P; Lesley SA; McPhillips TM; Miller MD; Morse A; Moy K; Ouyang J; Page R; Quijano K; Reyes R; Robb A; Sims E; Spraggon G; Stevens RC; van den Bedem H; Velasquez J; Vincent J; von Delft F; Wang X; West B; Wolf G; Xu Q; Hodgson KO; Wooley J; Wilson IA
    Proteins; 2004 Aug; 56(3):629-33. PubMed ID: 15229897
    [No Abstract]   [Full Text] [Related]  

  • 24. Crystal structure of phosphoribosylformylglycinamidine synthase II (smPurL) from Thermotoga maritima at 2.15 A resolution.
    Mathews II; Krishna SS; Schwarzenbacher R; McMullan D; Abdubek P; Ambing E; Canaves JM; Chiu HJ; Deacon AM; DiDonato M; Elsliger MA; Godzik A; Grittini C; Grzechnik SK; Hale J; Hampton E; Han GW; Haugen J; Jaroszewski L; Klock HE; Koesema E; Kreusch A; Kuhn P; Lesley SA; Levin I; Miller MD; Moy K; Nigoghossian E; Paulsen J; Quijano K; Reyes R; Spraggon G; Stevens RC; van den Bedem H; Velasquez J; White A; Wolf G; Xu Q; Hodgson KO; Wooley J; Wilson IA
    Proteins; 2006 Jun; 63(4):1106-11. PubMed ID: 16544324
    [No Abstract]   [Full Text] [Related]  

  • 25. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
    Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B
    J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome.
    Begley MJ; Taylor GS; Kim SA; Veine DM; Dixon JE; Stuckey JA
    Mol Cell; 2003 Dec; 12(6):1391-402. PubMed ID: 14690594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-function relationships in a bacterial DING protein.
    Ahn S; Moniot S; Elias M; Chabriere E; Kim D; Scott K
    FEBS Lett; 2007 Jul; 581(18):3455-60. PubMed ID: 17612529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide.
    Phan J; Lee K; Cherry S; Tropea JE; Burke TR; Waugh DS
    Biochemistry; 2003 Nov; 42(45):13113-21. PubMed ID: 14609321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1.15 A crystal structure of the X. tropicalis Spred1 EVH1 domain suggests a fourth distinct peptide-binding mechanism within the EVH1 family.
    Harmer NJ; Sivak JM; Amaya E; Blundell TL
    FEBS Lett; 2005 Feb; 579(5):1161-6. PubMed ID: 15710406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of the methyltransferase domain of human TARBP1.
    Wu H; Min J; Zeng H; Plotnikov AN
    Proteins; 2008 Jul; 72(1):519-25. PubMed ID: 18412263
    [No Abstract]   [Full Text] [Related]  

  • 32. Crystal structure of Saccharomyces cerevisiae Ygr203w, a homolog of single-domain rhodanese and Cdc25 phosphatase catalytic domain.
    Yeo HK; Lee JY
    Proteins; 2009 Aug; 76(2):520-4. PubMed ID: 19382206
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
    Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A genome-wide survey of human tyrosine phosphatases.
    Bhaduri A; Sowdhamini R
    Protein Eng; 2003 Dec; 16(12):881-8. PubMed ID: 14983067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases.
    Eswaran J; von Kries JP; Marsden B; Longman E; Debreczeni JE; Ugochukwu E; Turnbull A; Lee WH; Knapp S; Barr AJ
    Biochem J; 2006 May; 395(3):483-91. PubMed ID: 16441242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Singlet oxygen inactivates protein tyrosine phosphatase-1B by oxidation of the active site cysteine.
    von Montfort C; Sharov VS; Metzger S; Schöneich C; Sies H; Klotz LO
    Biol Chem; 2006; 387(10-11):1399-404. PubMed ID: 17081112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of energetic and dynamic coupling networks in a PDZ domain protein.
    Fuentes EJ; Gilmore SA; Mauldin RV; Lee AL
    J Mol Biol; 2006 Dec; 364(3):337-51. PubMed ID: 17011581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of human PRL-3, the phosphatase associated with cancer metastasis.
    Kim KA; Song JS; Jee J; Sheen MR; Lee C; Lee TG; Ro S; Cho JM; Lee W; Yamazaki T; Jeon YH; Cheong C
    FEBS Lett; 2004 May; 565(1-3):181-7. PubMed ID: 15135076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
    Evdokimov AG; Pokross M; Walter R; Mekel M; Cox B; Li C; Bechard R; Genbauffe F; Andrews R; Diven C; Howard B; Rastogi V; Gray J; Maier M; Peters KG
    Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1435-45. PubMed ID: 17139078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tethering.
    Erlanson DA; McDowell RS; He MM; Randal M; Simmons RL; Kung J; Waight A; Hansen SK
    J Am Chem Soc; 2003 May; 125(19):5602-3. PubMed ID: 12733877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.